Takeda Pharmaceutical and Hitachi jointly announced February 20 the establishment of Hitachi Inspharma, Ltd., a joint venture to support and develop information systems for the medical and pharmaceutical industries.
Capitalized at 225 million yen ($1.9 mil), Hitachi Inspharma will initially provide outsourcing services to Takeda Pharmaceutical. Hitachi retains a 66% stake in the new company while Takeda Pharmaceutical holds the remaining 34%.
Upon expiration of the two-year joint venture period, the newly-established company will become a wholly owned subsidiary of Hitachi. Hitachi Inspharma aims to generate approximately 4 billion yen ($33.8 mil) in sales in fiscal 2006.
By Aki Tsukioka, JCN Staff Writer
Company profile
Copyright © 2006 JCN. All rights reserved. A division of Japan Corporate News Network KK.